BioSpace News Archive

AmerisourceBergen, Cardinal Health and McKesson announced this morning that they have agreed to a $215 million settlement with two Ohio counties, Cuyahoga and Summit, in the first track of the multi-district opioid litigation.

Hoffman will lead all marketing efforts for Pharmavite, including brand development, consumer insights, advertising and organization development.

Vertex Pharmaceuticals Incorporated announced that the Spanish Government has approved terms for the national reimbursement of ORKAMBI® and SYMKEVI® in combination with KALYDECO® for eligible patients in Spain living with cystic fibrosis

Senator William Brownsberger and State Representatives Jon Santiago and Dan Cullinane to Highlight Importance of Proper Drug Disposal

Dalian Fusheng Pharmaceutical Company Co., Ltd., a major pharmaceutical company in Dalian, China has contributed $100,000 to the Milstein Medical Asian American Partnership Foundation to support translational research at Johns Hopkins University focusing on aging immune system and viral infections.

INNATE PHARMA S.A. (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate Pharma” or the “Company”), today announced the closing of its previously announced global offering to specified categories of investors of an aggregate of 14,375,000 new ordinary shares,

Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma”) and Mylan N.V. (NASDAQ: MYL) (“Mylan”) today announced that data from studies of YUPELRI® (revefenacin) inhalation solution will be presented at CHEST 2019, the annual meeting of the American College of Chest Physicians, on Oct. 22 in New Orleans, LA.

Kala Pharmaceuticals, Inc. announced that the Company granted non-statutory stock options to two new employees as an inducement award outside the Company’s 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635.

There are more than 134,000 respiratory therapists in the U.S. Respiratory therapists work closely as part of medical teams to evaluate, treat and care for patients with breathing or other cardiopulmonary disorders.

Transaction Bolsters Carlisle’s Presence in Attractive Medical Device Segment